Some Older Adults Are Being Charged Over $300 for the New R.S.V. Vaccine

https://nyti.ms/3KWunEJ
Health Insurance and Managed Care, Drugs (Pharmaceuticals), Vaccination and Immunization, Medicare, Respiratory Syncytial Virus (RSV), Centers for Medicare and Medicaid Services, Advisory Committee on Immunization Practices
By Dana G. Smith from NYT Well